Abcepta is one of the world’s largest original manufacturers of antibodies and peptides for life science research. The company develops and commercialize products and services that advance innovation life science discovery. Abcepta’s 45,000+ antibodies target proteins in key areas of neuroscience, cancer, immunology, metabolism, developmental biology, stem cells, cardiovascular and microbiology. Abcepta custom services include custom antibody development and peptide synthesis. Abcepta works with pharmaceutical companies and CROs in the development of IVD products and anti-drug antibodies (ADA) for use in pharmacokinetic bridging ELISAs and as reference standards in ADA assays to support clinical development of biotherapeutic drugs.